# Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.

> **NCT01913990** · PHASE4 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 323 (estimated)

## Conditions studied

- Emesis

## Interventions

- **DRUG:** Dexamethasone, Ondansetron, Aprepitant
- **OTHER:** Arm A: Standard Anti-emetic regimen

## Key facts

- **NCT ID:** NCT01913990
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 323 (ESTIMATED)
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913990, "Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01913990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*